Martha Carlin is a transformational leader who has leveraged her extensive business experience as a turnaround expert to become a leading citizen scientist in the field of the microbiome. With a focus on improving human health, Carlin founded The BioCollective, a company dedicated to studying the microbiome and its impact on human health. Through The BioCollective, she has conducted groundbreaking research on the gut microbiome and its relationship to diseases such as Parkinson’s. Carlin also launched the BiotiQuest brand of targeted probiotics, which offers targeted probiotics to restore lost microbiome function and restore balance. Her innovative approach has earned recognition from the National Institutes of Health and the White House Microbiome Initiative, making her a key figure in the field of microbiome research.
